Forecast: Basic Pharmaceutical Products and Preparations Manufacturing Output in France

Between 2013 and 2023, the output of Basic Pharmaceutical Products and Preparations Manufacturing in France showed a consistent upward trend from €25.58 billion to €34.11 billion, albeit with some minor fluctuations in the early years. The year-on-year variations revealed a healthy growth overall, particularly notable from 2021 to 2023, where the annual growth rates were 3.24%, 7.29%, and 4.07%, respectively. The compound annual growth rate (CAGR) over the last 5 years stood at 4.54%, indicating robust performance in recent years.

Forecasting ahead from 2024 to 2028, the projected output continues to rise, reaching €41.63 billion in 2028. The forecasted 5-year CAGR is 3.15%, suggesting a steady growth trajectory. This anticipated progress highlights the sector's resilience and potential for continuous development.

Future trends to watch for:

• Impact of technological advancements in pharmaceutical manufacturing.
• Shifts in regulatory policies and their implications on production costs and competitiveness.
• Potential effects of global supply chain disruptions and geopolitical factors.
• Evolution in consumer demand for innovative and generic pharmaceutical products.